as on February 13, 2026 at 7:59 am IST
Day's Low
Day's High
3.92%
Downside
1.96%
Upside
52 Week's Low
52 Week's High
13.73%
Downside
305.88%
Upside
Check Humacyte Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$194.9M
EPS (TTM)
-0.384
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-8.28
Industry PE ratio
0PEG Ratio
0EBITDA
-97.3M
Revenue (TTM)
1.6M
Profit Margin
0.00%
Return On Equity TTM
-249.75%
Track how Humacyte Inc P/E has moved over time to understand its valuation trends.
Humacyte Inc in the last 5 years
Lowest (-23.35x)
December 31, 2022
Industry (0.00x)
February 13, 2026
Today (-8.28x)
February 13, 2026
Highest (11.98x)
September 30, 2022
Today’s Price to Earnings Ratio: -8.28x
Compare market cap, revenue, PE, and other key metrics of Humacyte Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $194.9M | NA | -8.28 | 0.00% | |
| BUY | $118.3B | 117.32% | 32.46 | 31.35% | |
| BUY | $42.5B | 95.34% | 1109.48 | 1.36% | |
| NA | $38.9B | NA | 662.77 | 1.38% | |
| BUY | $82.4B | 61.37% | 18.8 | 31.41% |
The Humacyte Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Humacyte Inc investment value today
Current value as on today
₹30,212
Returns
Returns from Humacyte Inc Stock
Dollar Returns*
₹4,192 (+4.19%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Humacyte Inc. Average target price of $7.71
Get share price movements and forecasts by analysts on Humacyte Inc.
What analysts predicted
86.77%UPSIDE
Target Price
$7.71
Current Price
$1.02
Analyzed by
12 Analysts
Target
$7.71
Humacyte Inc target price $7.71, a slight upside of 86.77% compared to current price of $1.02. According to 12 analysts rating.
Search interest for Humacyte Inc Stock has increased by 60% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:60% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 09 February
Mon, 06:30 PM
-Humacyte announces DoD funding for biologic vascular repair technologies in traumatic injuries, enhancing support for its bioengineered blood vessels.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 301.0K → 753.0K (in $), with an average increase of 60.0% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -37.65M → -17.51M (in $), with an average increase of 115.1% per quarter
Price Rise
![]()
In the last 7 days, HUMA stock has moved up by 7.6%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 43.3% return, outperforming this stock by 109.7%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 55.8% return, outperforming this stock by 130.0%
| Organisation | Humacyte Inc |
| Headquarters | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
| Industry | Healthcare |
| CEO | Dr. Laura E. Niklason M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Laura E. Niklason M.D., Ph.D. | Founder, President, CEO & Director |
Mr. Dale A. Sander | CFO, Chief Corporate Development Officer & Treasurer |
Ms. Sabrina Osborne GPHR, SPHR | Chief People Officer |
Dr. Shamik J. Parikh M.D. | Chief Medical Officer |
Ms. Lisa Molyneux | Executive Vice President of Enterprise Planning & Analysis |
Dr. Heather Connelly Ph.D. | Senior Vice President of Quality |
Humacyte Inc share price today is $1.02 as on at the close of the market. Humacyte Inc share today touched a day high of $1.04 and a low of $0.98.
Humacyte Inc share touched a 52 week high of $4.14 on and a 52 week low of $0.88 on . Humacyte Inc stock price today i.e. is closed at $1.02,which is 75.36% down from its 52 week high and 15.91% up from its 52 week low.
Humacyte Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Humacyte Inc (HUMA) shares with as little as ₹90.553 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.53 in Humacyte Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Humacyte Inc share’s latest price of $1.02 as on February 13, 2026 at 2:29 am IST, you will get 9.8039 shares of Humacyte Inc. Learn more about
fractional shares .